Regional MedTech Strategist at E*HealthLine - Europe Global Office
Many are probably already familiar with “Biomarkers”. This is a term usually used to describe a molecule or gene that indicates a change in a person’s health...
Medical technology companies have a lot to consider when developing new products: a successful device must address an unmet need, deliver value to users and...
AI – Artificial Intelligence – sounds like another buzzword floating in the air of Brussels when we talk about future R&D priorities. There are many...
Back in 2018 the UK signed up, alongside thirteen other nations [1] , to the Global Digital Health Partnership (GDHP). This global network brings together...
Regional MedTech Strategist at E*HealthLine - Europe Global Office
A new class of therapies known as "Digital Therapeutics" is predicting and transforming measurable outcomes for the future of medical care. It is reshaping the...
